Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2024-12-10 Major Shareholding Noti…
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
持股5%以上股东拟减持公司股份不超过1%的预披露公告
Major Shareholding Notification Classification · 100% confidence The document is a pre-disclosure announcement regarding a shareholder holding more than 5% of the company's shares planning to reduce their holdings by no more than 1%. It includes details about the shareholder, the planned reduction amount, method, period, and compliance with relevant laws and regulations. The document does not contain financial statements or performance data, nor is it a report or presentation. It is a regulatory announcement about a major shareholding change, specifically a planned reduction in shareholding by a significant shareholder. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, confirming this classification.
2024-12-10 Chinese
2024年股权激励计划限制性股票首次授予结果公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the results of the first grant of restricted stock under the company's 2024 equity incentive plan. It details the number of shares granted, the recipients, the grant price, the vesting and lock-up periods, performance conditions, and the impact on the company's financials and shareholding structure. It also includes information about the verification of subscription funds by an accounting firm. The document is not a full financial report, earnings release, or management discussion, but rather a formal announcement of a capital change related to share issuance and equity incentives. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief notice or a regulatory filing fallback. Confidence is high due to the detailed nature of the announcement and the focus on share grants and capital structure changes.
2024-11-26 Chinese
关于变更项目合伙人及签字注册会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from 湖北一致魔芋生物科技股份有限公司 regarding a change in the signing certified public accountant (CPA) for the company's 2024 audit. It details the replacement of one CPA with another for the audit engagement and confirms that this change will not affect the audit work. The document does not contain any financial statements or audit results itself, but rather informs about a personnel change related to the audit. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related announcements about audit personnel changes, excluding full annual reports. The document length is short and it is not a report publication announcement or certification letter, so AR is appropriate. FY 2024
2024-11-14 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is a stock-related announcement from 湖北一致魔芋生物科技股份有限公司 regarding the lifting of trading restrictions on certain shares (解除限售公告). It details the number of shares being unlocked, the shareholders involved, their roles, and the reasons for unlocking. It also discusses the post-unlock shareholding structure and compliance with relevant stock exchange rules. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share status changes, specifically about lifting share lock-up restrictions, which fits best under Share Issue/Capital Change (SHA) as it relates to changes in share capital conditions and trading status. The document length is 2471 characters, which is short and focused on this specific capital change event, not a full report or earnings release.
2024-11-12 Chinese
投资者关系活动记录表
Call Transcript Classification · 90% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details a specific investor relations event held between November 9 and November 12, 2024, including questions and answers about the company's operations, financial performance, and strategic outlook. The content is a Q&A format from an investor relations meeting rather than a formal earnings release or financial report. The document length is 2069 characters, which is relatively short and focused on investor relations activities rather than comprehensive financial statements or official earnings announcements. It does not contain formal financial statements or a summary of quarterly results in the style of an Earnings Release (ER), nor is it a full Interim/Quarterly Report (IR). It is not an Annual Report (10-K) or any other formal regulatory filing. The document fits best under the category of Investor Presentation (IP) or Call Transcript (CT), but since it is a record of an investor relations activity with Q&A, it aligns most closely with a Call Transcript (CT) type, which includes full text transcripts of company conference calls or investor Q&A sessions. Therefore, the most appropriate classification is Call Transcript (CT).
2024-11-12 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding abnormal stock price fluctuations of the company 湖北一致魔芋生物科技股份有限公司. It details the stock price changes over specific recent trading days, the company's investigation into possible causes, and confirms no undisclosed material information or insider trading occurred during the period. The document references compliance with the Beijing Stock Exchange trading rules and provides a risk warning to investors. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about stock trading behavior and company disclosures rather than a financial report or meeting material.
2024-10-28 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.